Surging Oncology Research Yields Big Approval Dividends and Lucrative Payoffs, Study Says

By PacConAdmin | May 26, 2022

Oncology research and drug development continue to surge globally, with 159 new medications launched since 2012 — and a record 30 of those in 2021 — according to the life science research analytics firm IQVIA Institute.
Source: Drug Industry Daily

Posted in Drug Industry Daily